KRKA
Pharmaceutical Partner
KRKA is a leading generics pharmaceutical company with over 70 years of experience produced worldwide trusted medicines. We manufacture our products with a core principle: caring for people's health. Krka's portfolio includes a wide range of medications for the treatment of cardiovascular, central nervous system, gastrointestinal and pain disorders. The most popular are Co-Amlessa, Amlessa, Co-Prenessa, Co- Valodip, Valodip, Roxera Plus, Telmista, Nalgesin, Nolpaza, Elicea, Mirzaten and Kventiax. Krka produces traditional medications and introduces innovations, including fixed-dose combinations in a single tablet, new formulations and dosages. More than 100 million patients in over 70 countries take Krka medications daily.